Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Purification and Detection

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino acid epitope tag widely adopted in molecular biology for protein detection and purification (APExBIO). Its high solubility—measured at ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water—enables flexible integration into diverse experimental buffers. The HA peptide facilitates competitive elution of HA-tagged fusion proteins from Anti-HA antibodies during immunoprecipitation assays (Wei et al., 2021). Purity (>98%) is confirmed by HPLC and mass spectrometry, ensuring reproducibility and specificity. Proper storage (desiccated at -20°C) is necessary for stability, as extended storage of solutions is not recommended (APExBIO).

Biological Rationale

The HA tag peptide derives from the human influenza virus hemagglutinin protein, a type I membrane glycoprotein involved in viral entry. The nine-residue sequence (YPYDVPDYA) is not present in most mammalian proteomes, minimizing cross-reactivity in detection assays (Wei et al., 2021). The small size of the epitope tag allows for minimal perturbation to the fusion protein’s structure and function. The HA tag is recognized with high specificity and affinity by commercially available monoclonal antibodies, facilitating sensitive detection and purification. The tag’s adoption enables standardized workflows in protein interaction studies, where precise identification and isolation of target proteins are required. For advanced applications in quantitative proteomics and ubiquitin signaling, the HA peptide supports multiplexed detection and protein modification analysis (see related article—this article extends prior discussions by providing quantitative solubility data and benchmarking purity).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide operates as a competitive binder for anti-HA antibodies. In immunoprecipitation workflows, HA-tagged fusion proteins are captured using immobilized anti-HA antibodies, such as those conjugated to magnetic beads. Addition of an excess of free HA peptide (typically in molar excess relative to the antibody binding sites) disrupts the antibody-protein interaction via competitive inhibition, releasing the HA-tagged protein into solution. This elution mechanism is highly specific, relying on the antibody’s recognition of the nine-residue epitope. The peptide’s high solubility ensures efficient elution even at elevated concentrations required for complete recovery of bound proteins. The process is compatible with a wide range of buffers and can be executed at 4°C to maintain protein stability (see internal guide—this article adds new data on elution efficiency and storage best practices).

Evidence & Benchmarks

• HA tag sequence (YPYDVPDYA) supports high-specificity immunoprecipitation and detection with minimal cross-reactivity in mammalian lysates (Wei et al., 2021).
• The APExBIO Influenza Hemagglutinin (HA) Peptide (SKU A6004) exceeds 98% purity as verified by HPLC and mass spectrometry, minimizing sample contamination (APExBIO).
• Solubility values: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water (measured at 25°C, pH 7.4), enabling preparation of concentrated stock solutions for diverse assays (APExBIO).
• Competitive elution of HA-tagged fusion proteins is effective at 1–2 mM HA peptide concentrations, with elution yields exceeding 90% under standard immunoprecipitation conditions (internal benchmark).
• Stable storage is achieved by keeping the lyophilized peptide desiccated at -20°C; peptide solutions are stable for <1 week at 4°C but lose activity upon repeated freeze-thaw cycles (APExBIO).

Applications, Limits & Misconceptions

The HA tag peptide is primarily utilized for the detection, purification, and elution of HA-tagged fusion proteins in immunoprecipitation and Western blotting workflows. It enables multiplexed protein-protein interaction studies, mapping ubiquitin signaling, and quantitative recovery of tagged proteins (internal article—the present review updates mechanistic insights for cancer signaling research). The peptide is compatible with a wide range of lysis and wash buffers, including non-denaturing and denaturing conditions. Its versatility extends to both manual and automated platforms.

Common Pitfalls or Misconceptions

• The HA peptide does not enable elution of non-HA-tagged proteins; its specificity is limited to the YPYDVPDYA epitope.
• Excessive peptide concentrations (>5 mM) may inhibit downstream assays by antibody saturation or buffer incompatibility.
• Long-term storage of peptide solutions (more than 1 week at 4°C) leads to hydrolysis or aggregation, reducing functional yield.
• Epitope masking due to protein folding or complex formation may reduce accessibility, leading to suboptimal immunoprecipitation yields.
• Use in in vivo models is limited by rapid peptide clearance and potential immunogenicity; this peptide is not validated as a therapeutic agent.

Workflow Integration & Parameters

For optimal use, the APExBIO Influenza Hemagglutinin (HA) Peptide should be reconstituted in suitable solvents according to the required assay concentration (commonly 1–2 mM for elution). The peptide is compatible with standard anti-HA antibodies (monoclonal or polyclonal) and Anti-HA Magnetic Beads. Elution efficiency is maximized by incubating the antibody-bound resin with the peptide at 4°C for 30–60 minutes.

Recommended buffer conditions: 20–50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1% NP-40 or Triton X-100 for non-denaturing extractions. The peptide is suitable for sequential elution in multiplexed interaction studies. For advanced applications in E3 ligase substrate identification and quantitative proteomics, the high solubility and purity of the A6004 kit are crucial (related article—this piece provides updated storage and workflow recommendations).

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide from APExBIO establishes a gold-standard for epitope tagging in protein purification and detection. Its high specificity, solubility, and purity enable robust, scalable workflows in molecular biology, proteomics, and translational research. Ongoing advances in antibody engineering and multiplexed tagging will further expand the utility of the HA peptide for quantitative and mechanistic studies. Researchers are advised to reference validated product specifications and storage guidelines to ensure reproducibility (see full product details).